XBiotech Inc.
XBIT
$2.32
-$0.09-3.73%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -3.30% | -48.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.56% | -53.24% | |||
| Operating Income | 4.56% | 53.24% | |||
| Income Before Tax | -241.78% | 84.08% | |||
| Income Tax Expenses | 264.29% | -3.45% | |||
| Earnings from Continuing Operations | -242.14% | 83.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -242.14% | 83.87% | |||
| EBIT | 4.56% | 53.24% | |||
| EBITDA | 4.70% | 55.01% | |||
| EPS Basic | -242.19% | 83.87% | |||
| Normalized Basic EPS | -242.09% | 84.09% | |||
| EPS Diluted | -242.19% | 83.87% | |||
| Normalized Diluted EPS | -242.09% | 84.09% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||